Directory
>
Aya Jakobovits
Aya Jakobovits
Board Member | Adicet Bio, Inc
Los Angeles, California, United States
Aya Jakobovits
Summary
Aya Jakobovits is an accomplished professional in the biotechnology sector, currently serving as a Board Member at Dorian Therapeutics. With a rich history in leadership roles, she has founded and led multiple organizations, including Adicet Bio, where she was instrumental in shaping its strategic direction. Her extensive experience spans over three decades, with significant positions at notable companies such as Kite Pharma and Astellas Pharma. Aya's expertise lies in commercial physical research and financial investment activities, showcasing her versatility in both scientific and business arenas. A strong advocate for innovation, she has been involved in various initiatives aimed at advancing healthcare solutions. Despite her busy schedule, she remains passionate about mentoring the next generation of leaders in the biotech field. Aya is known for her strategic thinking and ability to navigate complex challenges, making her a respected figure in her industry.
Aya Jakobovits
Work Experience
Board Member at
Dorian Therapeutics
January 2021 - Present
Board Member at
YEDA - Technology Transfer Company of Weizmann Institute of Science
January 2019 - Present
Founder and Board Member at
Adicet Bio, Inc
January 2018 - Present
Board Member at
Ucla
January 2017 - Present
Board Member at
Alliance For Cancer Gene Thrpy
January 2015 - January 2019
Founder, President and CEO at
Adicet Bio, Inc
January 2015 - January 2018
Venture Partner at
OrbiMed
December 2011 - January 2016
President & CEO at
Kite Pharma
January 2010 - January 2013
Executive Vice President, Head, Research and Development at
Astellas Pharma Singapore
January 2007 - January 2010
Senior Vice President, Technology and Corporate Development Chief Scientific Officer at
Agensys International
January 1999 - January 2007
Director, Discovery Research and Principal Scientist at
Abgenix
January 1996 - January 1999
Director, Molecular Immunology at
Cell Genesys
January 1989 - January 1996
Postdoctoral fellow at
Genentech Foundation
January 1986 - January 1989
Frequently Asked Questions about Aya Jakobovits
What is Aya Jakobovits email address?
Aya Jakobovits's primary email address is ***********@agensys.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Aya Jakobovits work for?
Aya Jakobovits is a Board Member at Adicet Bio, Inc, a company specializing in Commercial physical research.
How can I directly contact Aya Jakobovits?
To contact Aya Jakobovits directly, you can use the email address ***********@agensys.com. Complete contact information is available upon registration with Muraena.
Who is Aya Jakobovits?
Aya Jakobovits is an accomplished professional in the biotechnology sector, currently serving as a Board Member at Dorian Therapeutics. With a rich history in leadership roles, she has founded and led multiple organizations, including Adicet Bio, where she was instrumental in shaping its strategic direction. Her extensive experience spans over three decades, with significant positions at notable companies such as Kite Pharma and Astellas Pharma. Aya's expertise lies in commercial physical research and financial investment activities, showcasing her versatility in both scientific and business arenas. A strong advocate for innovation, she has been involved in various initiatives aimed at advancing healthcare solutions. Despite her busy schedule, she remains passionate about mentoring the next generation of leaders in the biotech field. Aya is known for her strategic thinking and ability to navigate complex challenges, making her a respected figure in her industry.
Aya`s contact details
***********@agensys.com
***@doriantherapeutics.com
***********@adicetbio.com
**@ucla.edu
***********@kitepharma.com
Colleagues
Vice President, Cell Therapy Development and Manufacturing
Senior Vice President and Chief Medical Officer
Executive Director, Information Technology
Chief Regulatory Officer
VP, Nonclinical Development
VP and Head of Clinical Operations
VP, Head of Program Leadership and Program Management
Executive Director, Regulatory CMC
Executive Director, Business Development and Portfolio Strategy
Board Member